{
    "2020-03-03": [
        [
            {
                "time": "",
                "original_text": "贝达药业：拟非公开发行募集资金不超过10.02亿元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "非公开发行",
                        "募集资金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：定增募资不超过10.02亿元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "定增",
                        "募资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：董事长丁列明拟减持不超过27.05万股 拟减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "董事长",
                        "丁列明",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：3名股东减持期过半 合计减持832.08万股 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "减持"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：董事长丁列明拟减持不超过总股本0.07% 减持股份数量",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "董事长",
                        "丁列明",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "多家药企产品获批临床试验，临床用药或日益丰富",
                "features": {
                    "keywords": [
                        "药企",
                        "产品",
                        "临床试验",
                        "临床用药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}